Redox control of the NLRP1 inflammasome
NLRP1 炎症小体的氧化还原控制
基本信息
- 批准号:10277155
- 负责人:
- 金额:$ 51.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-15 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAntioxidantsAutoimmune DiseasesAutoimmunityBindingBiologicalBiological AssayCASP1 geneCell DeathCell membraneCellsCleaved cellCommunicable DiseasesComplexDataElectron TransportEnzymesGlutathioneGlutathione DisulfideGoalsHomeostasisHydrogen PeroxideHyperactivityImmune systemInflammasomeInflammatoryInnate Immune SystemInterleukin-18KnowledgeLaboratoriesLeucine-Rich RepeatLinkLyticMalignant NeoplasmsMediatingMetabolic stressMitochondriaMolecularMonitorMultiprotein ComplexesMutationN-terminalNatural ImmunityNucleotidesNutrientOxidantsOxidation-ReductionOxidative StressOxidesOxidoreductasePathway interactionsPatientsPattern recognition receptorPeptide HydrolasesPlayProcessProteinsProteolysisPublic HealthReactive Oxygen SpeciesReagentReporterResearchResearch Project GrantsRoleSelenocysteineSerine Proteinase InhibitorsSignal TransductionSiteSourceTXN geneTestingTherapeuticTimeWorkbasecytokinedisease-causing mutationglutathione peroxidaseinhibitor/antagonistmarenostrinpathogenpreventrecruitsmall molecule inhibitorstress reduction
项目摘要
PROJECT SUMMARY
Inflammasomes detect intracellular danger-associated signals and trigger an inflammatory form of cell death
called pyroptosis. The danger signals that the related NLRP1 and CARD8 inflammasomes sense are unknown
and represent a major knowledge gap. Interestingly, small-molecule inhibitors of the serine proteases DPP8
and DPP9 (DPP8/9) were recently discovered to induce a danger signal that activates the NLRP1 and CARD8
inflammasomes. However, DPP8/9 inhibitors, in contrast to other inflammasome activators, induce pyroptosis
in only a fraction of sensitive cells over relatively long time periods. Thus, it is possible that the co-occurrence
of a second danger signal with DPP8/9 inhibition is required for full and rapid NLRP1 and CARD8 activation.
The central hypothesis of this application is that a lack of reactive oxygen species, or reductive stress, is the
second danger signal required to fully activate these inflammasomes. This hypothesis has been formulated on
the basis of preliminary data produced in the applicant’s laboratory and described in the application. The long-
term goal of this project is to understand why reductive stress is a danger signal that is closely monitored by
the innate immune system. The immediate objective of this application is to determine the molecular
mechanism by which reductive stress activates the NLRP1 and CARD8 inflammasomes. This project consists
of three specific aims: 1) to characterize the impact of oxidants and antioxidants on NLRP1 and CARD8
activation; 2) to determine the mechanism of GPX1-mediated NLRP1 and CARD8 inactivation; and 3) to
determine how TRX1 modulates NLRP1 activation. Successful completion of this project will fill a critical
knowledge gap by showing that reductive stress is a key danger signal that activates the NLRP1 and CARD8
inflammasomes. Overall, this work holds tremendous promise to reveal a fundamental new connection
between metabolic stress and innate immunity, and to eventually enable these complex inflammasomes to be
harnessed for therapeutic benefit.
项目摘要
炎性小体检测细胞内与细胞凋亡相关的信号,并触发细胞死亡的炎症形式
叫做焦亡相关的NLRP 1和CARD 8炎性小体感知的危险信号未知
这是一个重大的知识缺口。有趣的是,丝氨酸蛋白酶DPP 8的小分子抑制剂
最近发现DPP 8和DPP 9(DPP 8/9)诱导激活NLRP 1和CARD 8的危险信号
炎性小体然而,与其他炎性体激活剂相反,DPP 8/9抑制剂诱导焦亡
在相对较长的时间内只在一小部分敏感细胞中发生。因此,同现有可能
NLRP 1和CARD 8的完全快速激活需要DPP 8/9抑制的第二个危险信号。
本申请的中心假设是缺乏活性氧物质或还原性应激是导致细胞死亡的原因。
第二个危险信号需要完全激活这些炎性小体。这一假设是根据
申请人实验室提供的初步数据的基础,并在申请中予以描述。很长的-
这个项目的长期目标是了解为什么还原压力是一个危险信号,
先天免疫系统本申请的直接目的是确定分子量。
还原应激激活NLRP 1和CARD 8炎性小体的机制。该项目由
三个具体目标:1)表征氧化剂和抗氧化剂对NLRP 1和CARD 8的影响
活化; 2)确定GPX 1介导的NLRP 1和CARD 8失活的机制;和3)
确定TRX 1如何调节NLRP 1激活。该项目的成功完成将填补一个关键的
通过显示还原性压力是激活NLRP 1和CARD 8的关键危险信号,
炎性小体总的来说,这项工作有巨大的希望揭示一个根本的新的联系,
代谢应激和先天免疫之间的联系,并最终使这些复杂的炎性小体
用于治疗
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Bachovchin其他文献
Daniel Bachovchin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel Bachovchin', 18)}}的其他基金
Prolidase Inhibitors as Therapeutic Agents for Acute Myeloid Leukemia
脯氨酸酶抑制剂作为急性髓系白血病的治疗剂
- 批准号:
10342970 - 财政年份:2022
- 资助金额:
$ 51.23万 - 项目类别:
Prolidase Inhibitors as Therapeutic Agents for Acute Myeloid Leukemia
脯氨酸酶抑制剂作为急性髓系白血病的治疗剂
- 批准号:
10573212 - 财政年份:2022
- 资助金额:
$ 51.23万 - 项目类别:
Characterizing the Mechanism of DPP8/9 Inhibitor-Induced Pyroptosis
DPP8/9 抑制剂诱导细胞焦亡机制的表征
- 批准号:
10334478 - 财政年份:2018
- 资助金额:
$ 51.23万 - 项目类别:
Characterizing the Mechanism of DPP8/9 Inhibitor-Induced Pyroptosis
DPP8/9 抑制剂诱导细胞焦亡机制的表征
- 批准号:
10091387 - 财政年份:2018
- 资助金额:
$ 51.23万 - 项目类别:
Characterizing the Mechanism of DPP8/9 Inhibitor-Induced Pyroptosis
DPP8/9 抑制剂诱导细胞焦亡机制的表征
- 批准号:
10733874 - 财政年份:2018
- 资助金额:
$ 51.23万 - 项目类别:
相似海外基金
Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
- 批准号:
24K18002 - 财政年份:2024
- 资助金额:
$ 51.23万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
- 批准号:
2222215 - 财政年份:2023
- 资助金额:
$ 51.23万 - 项目类别:
Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
- 批准号:
23K09272 - 财政年份:2023
- 资助金额:
$ 51.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
- 批准号:
10652764 - 财政年份:2023
- 资助金额:
$ 51.23万 - 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
- 批准号:
10730652 - 财政年份:2023
- 资助金额:
$ 51.23万 - 项目类别:
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
- 批准号:
22K11609 - 财政年份:2022
- 资助金额:
$ 51.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
- 批准号:
22K16720 - 财政年份:2022
- 资助金额:
$ 51.23万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
- 批准号:
RGPIN-2018-04107 - 财政年份:2022
- 资助金额:
$ 51.23万 - 项目类别:
Discovery Grants Program - Individual
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
- 批准号:
RGPIN-2019-05674 - 财政年份:2022
- 资助金额:
$ 51.23万 - 项目类别:
Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
- 批准号:
22K12824 - 财政年份:2022
- 资助金额:
$ 51.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




